Moderna, Rovi to collaborate on fill-finish manufacturing of mRNA-1273
Moderna and Laboratorios Farmacéuticos Rovi have entered into a collaboration for large-scale, commercial fill-finish manufacturing of mRNA-1273, the former’s mRNA vaccine candidate against COVID-19, at the latter’s facility in Madrid, Spain. Under the agreement terms, ROVI will offer vial filling and packaging capacity by procuring a new production line and equipment for compounding, filling, automatic […]